China Sunsine Chemical Holdings Ltd.

SGX:QES.SI

0.4 (SGD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SGD.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 3,490.4653,825.0613,725.1642,333.6642,691.6563,283.262,738.4032,036.8621,859.1272,077.2721,695.941,417.2821,175.089991.403718.389797.876619.539474.706
Cost of Revenue 2,691.5472,661.132,678.7041,733.3671,910.8292,157.361,950.2581,496.4581,367.1111,509.8821,387.911,173.408892.663767.324558.172571.087494.368356.466
Gross Profit 798.9181,163.9311,046.46600.297780.8271,125.9788.145540.404492.016567.39308.03243.874282.426224.079160.217226.789125.171118.24
Gross Profit Ratio 0.2290.3040.2810.2570.290.3430.2880.2650.2650.2730.1820.1720.240.2260.2230.2840.2020.249
Reseach & Development Expenses 119.362142.413110.80875.3290.758102.32123.6150000008.9341.2816.5620.6198.315
General & Administrative Expenses 207.279271.01231.417156.623185.943253.249227.776172.158164.921196.676136.331136.55289.35250.4142.8360.81123.38314.862
Selling & Marketing Expenses 102.74104.28995.96573.83296.65599.51775.7273.07467.85257.07850.18447.02337.77635.45323.52128.31420.3520.677
SG&A 310.019375.299327.382230.455282.598352.766303.496245.232232.773253.754186.515183.575127.12885.86366.35189.12543.73335.539
Other Expenses 027.21110.1620.8291.0022.1841.4180.7014.3441.6360.4510.2380.6700000
Operating Expenses 399.137473.522375.632303.672363.253441.405292.462241.757229.126249.714177.081177.13118.02785.3555.66798.25441.7442.286
Operating Income 399.781690.409699.119301.505453.083684.649477.457314.367282.646320.544132.33168.152166.299138.729104.55128.53583.43175.954
Operating Income Ratio 0.1150.180.1880.1290.1680.2090.1740.1540.1520.1540.0780.0480.1420.140.1460.1610.1350.16
Total Other Income Expenses Net 53.44843.3630-1.045-0.47726.935-0.571-4.8884.809-18.074-14.416-11.416-32.406-3.489-1.446-0.404-8.198-2.152
Income Before Tax 453.229733.772699.119300.46452.606711.584476.886309.479287.455302.47117.91556.736133.893135.24103.104128.13175.23373.802
Income Before Tax Ratio 0.130.1920.1880.1290.1680.2170.1740.1520.1550.1460.070.040.1140.1360.1440.1610.1210.155
Income Tax Expense 80.76491.328192.78981.68163.70770.308135.51987.77378.23482.2541.17524.72945.42519.97414.7821.421-0.82510.548
Net Income 372.465642.444506.33218.779388.899641.276341.367221.706195.158220.2276.7432.00799.429115.26688.324106.7176.05863.254
Net Income Ratio 0.1070.1680.1360.0940.1440.1950.1250.1090.1050.1060.0450.0230.0850.1160.1230.1340.1230.133
EPS 0.390.660.520.230.40.650.710.480.420.470.160.0690.210.240.180.220.190.18
EPS Diluted 0.390.660.520.230.40.650.710.480.420.470.160.0690.210.240.180.220.180.18
EBITDA 550.518853.718829.349423.88567.245782.254569.356410.349376.608407.888207.675131.495207.537162.326128.05148.07598.01587.508
EBITDA Ratio 0.1580.2230.2230.1820.2110.2380.2080.2010.2030.1960.1220.0930.1770.1640.1780.1860.1580.184